Simplify Asset Management
Las Vegas, NVfiles as Simplify Asset Management Inc.
$7.1bn in 136 US stocks at the end of 30 June 2026. The top 10 are 92.7% of the money. It changed about 3.3% of the portfolio this quarter.
Value
$7.1bn
Stocks
136
Top 10 share
92.7%
Turnover
3.3%
What changed this quarter
New
Bought for the first time this quarter.
- Simplify Exchange Traded FUNCAS0.2% of the fund
- Quest DiagnosticsDGX0.1% of the fund
- Elevance HealthELV0.1% of the fund
- Cardinal HealthCAH<0.1% of the fund
- Full House ResortsFLL<0.1% of the fund
- Blue Owl CapitalOWL<0.1% of the fund
- agilon healthAGL<0.1% of the fund
- SalesforceCRM<0.1% of the fund
- PennyMac Mortgage Investment TrustPMT<0.1% of the fund
- ImmunicIMUX<0.1% of the fund
- Braemar Hotels & ResortsBHR<0.1% of the fund
- IconICLR<0.1% of the fund
- Take TWO Interactive SoftwareTTWO<0.1% of the fund
- Colgate-PalmoliveCL<0.1% of the fund
- VtexVTEX<0.1% of the fund
- Beyond MeatBYND<0.1% of the fund
- 3D SystemsDDD<0.1% of the fund
Added
Bought more of a stock they already held.
- Simplify Exchange Traded FUNSBIL69.4% of the fund+7%
- Ishares TRAGG7.0% of the fund+23%
- PureCycle TechnologiesPCT0.3% of the fund+72%
- United TherapeuticsUTHR0.3% of the fund+33%
- Novo Nordisk A SNVO0.3% of the fund+54%
- Johnson & JohnsonJNJ0.3% of the fund+120%
- Warby ParkerWRBY0.3% of the fund+102%
- UnitedHealth GroupUNH0.2% of the fund+1355%
- Jazz PharmaceuticalsJAZZ0.2% of the fund+33%
- AbbVieABBV0.2% of the fund+33%
- BiohavenBHVN0.2% of the fund+16%
- Benitec BiopharmaBNTC0.2% of the fund+79%
- Thermo Fisher ScientificTMO0.2% of the fund+33%
- Gilead SciencesGILD0.1% of the fund+33%
- Achieve Life SciencesACHV0.1% of the fund+21%
- DanaherDHR0.1% of the fund+33%
- AmgenAMGN0.1% of the fund+32%
- CVS HealthCVS0.1% of the fund+32%
- AstrazenecaAZN<0.1% of the fund+32%
- EyePointEYPT<0.1% of the fund+23%
- Establishment Labs HoldingsESTA<0.1% of the fund+14%
- Vertex PharmaceuticalsVRTX<0.1% of the fund+32%
- Milestone PharmaceuticalsMIST<0.1% of the fund+122%
- Vaneck Bitcoin ETFHODL<0.1% of the fund+26%
- Guardant HealthGH<0.1% of the fund+32%
Cut
Sold some of their stake.
- Ishares TRIVV11.0% of the fund-5%
- Simplify Exchange Traded FUNTUA1.4% of the fund-13%
- Eli LillyLLY0.2% of the fund-12%
- Ishares Bitcoin Trust ETFIBIT0.2% of the fund-30%
- Align TechnologyALGN0.2% of the fund-37%
- 10x GenomicsTXG0.2% of the fund-17%
- TeslaTSLA<0.1% of the fund-4%
- Intuitive SurgicalISRG<0.1% of the fund-30%
- Simplify Exchange Traded FUNXXV<0.1% of the fund-7%
- Phathom PharmaceuticalsPHAT<0.1% of the fund-5%
- Corcept TherapeuticsCORT<0.1% of the fund-30%
- Abeona TherapeuticsABEO<0.1% of the fund-32%
- Cisco SystemsCSCO<0.1% of the fund-15%
- Celldex TherapeuticsCLDX<0.1% of the fund-23%
- MFA FinancialMFA<0.1% of the fund-20%
- COMPASS PathwaysCMPS<0.1% of the fund-28%
- Zevra TherapeuticsZVRA<0.1% of the fund-30%
- Western DigitalWDC<0.1% of the fund-5%
- Ocular TherapeutixOCUL<0.1% of the fund-10%
- CaterpillarCAT<0.1% of the fund-3%
- FortinetFTNT<0.1% of the fund-4%
- Applied MaterialsAMAT<0.1% of the fund-29%
- Lam ResearchLRCX<0.1% of the fund-28%
- Spotify TechnologySPOT<0.1% of the fund-6%
- Upstream BioUPB<0.1% of the fund-20%
Sold out
Sold their entire stake.
- Regeneron PharmaceuticalsREGN-100%
- 3MMMM-100%
- Simplify Exchange Traded FUNCTA-100%
- Alignment HealthcareALHC-100%
- Oculis Holding AGOCS-100%
- Viridian TherapeuticsVRDN-100%
- Oxford Lane CapitalOXLC-100%
- Vor BiopharmaVOR-100%
- Trevi TherapeuticsTRVI-100%
- 4D Molecular TherapeuticsFDMT-100%
- Palo Alto NetworksPANW-100%
- Kalaris TherapeuticsKLRS-100%
- ImmunicIMUX-100%
- Coherus OncologyCHRS-100%
- Corvus PharmaceuticalsCRVS-100%
- Ovid TherapeuticsOVID-100%
- Honeywell InternationalHON-100%
- BlackRockBLK-100%
- PepsiCoPEP-100%
- Connect Biopharma HoldingsCNTB-100%
- XCF GlobalSAFX-100%
- Ironwood PharmaceuticalsIRWD-100%
- Bit DigitalBTBT-100%
Holdings
- Simplify Exchange Traded FUNSBIL
- Share
- 69.4%
- Value
- $4.9bn
- Shares
- 49,141,862
+7%
- Ishares TRIVV
- Share
- 11.0%
- Value
- $781m
- Shares
- 1,042,652
-5%
- Ishares TRAGG
- Share
- 7.0%
- Value
- $499m
- Shares
- 5,041,755
+23%
- Simplify Exchange Traded FUNTUA
- Share
- 1.4%
- Value
- $98m
- Shares
- 4,810,740
-13%
- Simplify Exchange Traded FUNSPUC
- Share
- 1.1%
- Value
- $80m
- Shares
- 1,634,812
Held
- Simplify Exchange Traded FUNAGGH
- Share
- 0.6%
- Value
- $43m
- Shares
- 2,109,127
Held
- Simplify Exchange Traded FUNBUCK
- Share
- 0.6%
- Value
- $40m
- Shares
- 1,700,000
Held
- Simplify Exchange Traded FUNNMB
- Share
- 0.5%
- Value
- $39m
- Shares
- 1,553,376
Held
- Simplify Exchange Traded FUNQIS
- Share
- 0.5%
- Value
- $38m
- Shares
- 3,777,620
Held
- Simplify Exchange Traded FUNNXTI
- Share
- 0.4%
- Value
- $29m
- Shares
- 822,303
Held
- Ishares Bitcoin Trust ETFIBIT
- Share
- 0.2%
- Value
- $16m
- Shares
- 486,900
-30%
- Simplify Exchange Traded FUNXV
- Share
- 0.2%
- Value
- $15m
- Shares
- 624,406
Held
- Simplify Exchange Traded FUNCAS
- Share
- 0.2%
- Value
- $12m
- Shares
- 428,078
New
- Vaneck Bitcoin ETFHODL
- Share
- <0.1%
- Value
- $4m
- Shares
- 264,427
+26%
- Simplify Exchange Traded FUNLITL
- Share
- <0.1%
- Value
- $3m
- Shares
- 91,464
Held
- Simplify Exchange Traded FUNXXV
- Share
- <0.1%
- Value
- $3m
- Shares
- 116,500
-7%
- Simplify Exchange Traded FUNCTAP
- Share
- <0.1%
- Value
- $3m
- Shares
- 100,000
Held
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Simplify Exchange Traded FUNSBIL | 69.4% | $4.9bn | 49,141,862 | +7% |
| Ishares TRIVV | 11.0% | $781m | 1,042,652 | -5% |
| Ishares TRAGG | 7.0% | $499m | 5,041,755 | +23% |
| Simplify Exchange Traded FUNTUA | 1.4% | $98m | 4,810,740 | -13% |
| Simplify Exchange Traded FUNSPUC | 1.1% | $80m | 1,634,812 | Held |
| Simplify Exchange Traded FUNAGGH | 0.6% | $43m | 2,109,127 | Held |
| Simplify Exchange Traded FUNBUCK | 0.6% | $40m | 1,700,000 | Held |
| Simplify Exchange Traded FUNNMB | 0.5% | $39m | 1,553,376 | Held |
| Simplify Exchange Traded FUNQIS | 0.5% | $38m | 3,777,620 | Held |
| Plains GP Holdings LPPAGP | 0.4% | $31m | 1,272,360 | Held |
| Simplify Exchange Traded FUNNXTI | 0.4% | $29m | 822,303 | Held |
| PureCycle TechnologiesPCT | 0.3% | $25m | 3,048,190 | +72% |
| United TherapeuticsUTHR | 0.3% | $25m | 45,411 | +33% |
| Novo Nordisk A SNVO | 0.3% | $24m | 504,918 | +54% |
| Johnson & JohnsonJNJ | 0.3% | $19m | 72,879 | +120% |
| Warby ParkerWRBY | 0.3% | $18m | 587,066 | +102% |
| Eli LillyLLY | 0.2% | $18m | 14,715 | -12% |
| UnitedHealth GroupUNH | 0.2% | $18m | 42,212 | +1355% |
| Jazz PharmaceuticalsJAZZ | 0.2% | $17m | 68,560 | +33% |
| AbbVieABBV | 0.2% | $16m | 64,461 | +33% |
| Ishares Bitcoin Trust ETFIBIT | 0.2% | $16m | 486,900 | -30% |
| BiohavenBHVN | 0.2% | $15m | 1,040,255 | +16% |
| Simplify Exchange Traded FUNXV | 0.2% | $15m | 624,406 | Held |
| Benitec BiopharmaBNTC | 0.2% | $13m | 1,005,557 | +79% |
| Simplify Exchange Traded FUNCAS | 0.2% | $12m | 428,078 | New |
| Thermo Fisher ScientificTMO | 0.2% | $12m | 23,079 | +33% |
| Align TechnologyALGN | 0.2% | $11m | 66,847 | -37% |
| 10x GenomicsTXG | 0.2% | $11m | 292,938 | -17% |
| Quest DiagnosticsDGX | 0.1% | $11m | 49,715 | New |
| Gilead SciencesGILD | 0.1% | $10m | 81,325 | +33% |
| Elevance HealthELV | 0.1% | $10m | 25,577 | New |
| Achieve Life SciencesACHV | 0.1% | $9m | 1,432,105 | +21% |
| DanaherDHR | 0.1% | $8m | 42,834 | +33% |
| AmgenAMGN | 0.1% | $8m | 20,974 | +32% |
| CVS HealthCVS | 0.1% | $7m | 71,090 | +32% |
| AstrazenecaAZN | <0.1% | $6m | 34,188 | +32% |
| Cardinal HealthCAH | <0.1% | $6m | 26,924 | New |
| EyePointEYPT | <0.1% | $6m | 400,044 | +23% |
| Establishment Labs HoldingsESTA | <0.1% | $5m | 60,540 | +14% |
| Vertex PharmaceuticalsVRTX | <0.1% | $5m | 10,456 | +32% |
| Milestone PharmaceuticalsMIST | <0.1% | $4m | 3,349,379 | +122% |
| TeslaTSLA | <0.1% | $4m | 10,621 | -4% |
| Vaneck Bitcoin ETFHODL | <0.1% | $4m | 264,427 | +26% |
| Guardant HealthGH | <0.1% | $4m | 27,571 | +32% |
| Rithm CapitalRITM | <0.1% | $4m | 411,593 | +22% |
| Delcath SystemsDCTH | <0.1% | $3m | 264,770 | Held |
| GE HealthCare TechnologiesGEHC | <0.1% | $3m | 52,040 | +33% |
| Simplify Exchange Traded FUNLITL | <0.1% | $3m | 91,464 | Held |
| Intuitive SurgicalISRG | <0.1% | $3m | 7,492 | -30% |
| Simplify Exchange Traded FUNXXV | <0.1% | $3m | 116,500 | -7% |
| Phathom PharmaceuticalsPHAT | <0.1% | $3m | 249,267 | -5% |
| Simplify Exchange Traded FUNCTAP | <0.1% | $3m | 100,000 | Held |
| Corcept TherapeuticsCORT | <0.1% | $2m | 26,434 | -30% |
| Abeona TherapeuticsABEO | <0.1% | $2m | 345,416 | -32% |
| Pacira BioSciencesPCRX | <0.1% | $2m | 83,083 | +33% |
| Cisco SystemsCSCO | <0.1% | $2m | 16,904 | -15% |
| Celldex TherapeuticsCLDX | <0.1% | $2m | 53,134 | -23% |
| WalmartWMT | <0.1% | $2m | 16,890 | +19% |
| Abbott LaboratoriesABT | <0.1% | $2m | 20,546 | +33% |
| Dynex CapitalDX | <0.1% | $2m | 134,500 | +65% |
| Edwards LifesciencesEW | <0.1% | $2m | 18,668 | +33% |
| Kyverna TherapeuticsKYTX | <0.1% | $2m | 182,603 | +5% |
| MFA FinancialMFA | <0.1% | $2m | 167,746 | -20% |
| COMPASS PathwaysCMPS | <0.1% | $2m | 114,281 | -28% |
| Annaly Capital ManagementNLY | <0.1% | $2m | 71,839 | +45% |
| InsmedINSM | <0.1% | $2m | 14,190 | +32% |
| International Business MachinesIBM | <0.1% | $1m | 5,014 | +5% |
| Palantir TechnologiesPLTR | <0.1% | $1m | 12,021 | +3% |
| LeonaBioLONA | <0.1% | $1m | 149,279 | Held |
| Dell TechnologiesDELL | <0.1% | $1m | 3,172 | +3% |
| Berkshire HathawayBRK-B | <0.1% | $1m | 2,662 | Held |
| AGNC InvestmentAGNC | <0.1% | $1m | 115,485 | +12% |
| InventivaIVA | <0.1% | $1m | 313,483 | +38% |
| TG TherapeuticsTGTX | <0.1% | $1m | 21,269 | +33% |
| Aquestive TherapeuticsAQST | <0.1% | $1m | 278,723 | +19% |
| Full House ResortsFLL | <0.1% | $1m | 397,000 | New |
| Zevra TherapeuticsZVRA | <0.1% | $1m | 70,759 | -30% |
| QualcommQCOM | <0.1% | $1m | 5,471 | Held |
| Artiva BiotherapeuticsARTV | <0.1% | $983,144 | 101,355 | +336% |
| Seagate Technology HoldingsSTX | <0.1% | $955,350 | 990 | Held |
| Orchestra BioMed HoldingsOBIO | <0.1% | $946,655 | 219,387 | Held |
| Cooper CompaniesCOO | <0.1% | $945,281 | 13,182 | +33% |
| Palisade BIOPALI | <0.1% | $941,635 | 450,543 | +29% |
| Armour Residential REITARR | <0.1% | $940,555 | 53,900 | Held |
| Western DigitalWDC | <0.1% | $931,892 | 1,459 | -5% |
| Blue Owl CapitalOWL | <0.1% | $931,875 | 106,500 | New |
| MerckMRK | <0.1% | $920,960 | 7,167 | +10% |
| agilon healthAGL | <0.1% | $903,420 | 8,429 | New |
| MastercardMA | <0.1% | $809,947 | 1,577 | +3% |
| Ocular TherapeutixOCUL | <0.1% | $795,921 | 81,051 | -10% |
| ExxonMobil HoldingsXOM | <0.1% | $736,374 | 5,386 | +11% |
| StrykerSYK | <0.1% | $708,390 | 2,250 | +32% |
| SalesforceCRM | <0.1% | $692,437 | 4,420 | New |
| Chimera InvestmentCIM | <0.1% | $680,674 | 51,025 | Held |
| Boston ScientificBSX | <0.1% | $640,798 | 15,014 | +33% |
| General ElectricGE | <0.1% | $614,038 | 1,643 | Held |
| PennyMac Mortgage Investment TrustPMT | <0.1% | $603,480 | 53,500 | New |
| CaterpillarCAT | <0.1% | $594,214 | 558 | -3% |
| Fulcrum TherapeuticsFULC | <0.1% | $562,886 | 153,794 | +33% |
| Neurocrine BiosciencesNBIX | <0.1% | $558,694 | 3,315 | +32% |
Showing the largest 100 of 136.
Options (5)
- Ishares Bitcoin Trust ETFIBIT
- Type
- Call
- Value
- $48m
- Contracts
- 1,455,800
- Spdr Gold TRGLD
- Type
- Call
- Value
- $41m
- Contracts
- 110,000
- NvidiaNVDA
- Type
- Call
- Value
- $10m
- Contracts
- 52,000
- Invesco QQQ TRQQQ
- Type
- Call
- Value
- $2m
- Contracts
- 3,000
- AdobeADBE
- Type
- Call
- Value
- $574,056
- Contracts
- 2,800
| Company | Type | Value | Contracts |
|---|---|---|---|
| Ishares Bitcoin Trust ETFIBIT | Call | $48m | 1,455,800 |
| Spdr Gold TRGLD | Call | $41m | 110,000 |
| NvidiaNVDA | Call | $10m | 52,000 |
| Invesco QQQ TRQQQ | Call | $2m | 3,000 |
| AdobeADBE | Call | $574,056 | 2,800 |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 329.2% since 30 June 2025.
Where the money is
Health care5.1%
Energy0.4%
Materials0.3%
Technology0.2%
Real estate0.1%
Financial services0.1%
Retail & consumer0.1%
Everyday goods0.0%
Industrials0.0%
Media & telecom0.0%
Other93.5%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.